"CHI Saint Joseph Health - Saint Joseph East is dedicated to delivering high quality, compassionate care to Lexington and nearby communities. Visit us at 150 N. Eagle Creek Drive or call (859) 967-5000 for more information."

During the past decade, Saint Joseph Hospital East conducted 153 clinical trials. In the 10-year time frame, 153 clinical trials started and 49 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 46 clinical trials were completed. i.e. 70.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Hospital East" #1 sponsor was "National Cancer Institute (NCI)" with 85 trials, followed by "SWOG Cancer Research Network" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Hospital East" #1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Hospital East" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Saint Joseph Hospital East" in a lesser frequency.

Most popular intervention types in "Saint Joseph Hospital East" are "Drug" (136 trials), "Other" (108 trials), "Biological" (80 trials), "Procedure" (52 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (46 trials), "Questionnaire Administration" (32 trials), "Computed Tomography" (31 trials) and "Nivolumab" (29 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Hospital East" are 143 trials for "All" genders, 30 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Hospital East". undefined are not yet recruiting, 61 are recruiting, 87 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Saint Joseph Hospital East, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Hospital East, 3 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".